Controlling Damaging Protein Plaques Without Side-effects: Research Could Improve Alzheimer's Medication
Date: 27.4.2007
When protein plaque builds up in the blood, it can result in serious diseases such as heart disease and Alzheimer's. Cyclooxygenase (COX) inhibitors, a class of drugs under investigation for the treatment of one cause of plaque build-up, also exhibit negative side effects.
Researchers in the International Institute of Nano and Molecular Medicine at the University of Missouri-Columbia are studying the possible use of carboranes, which are clusters of boron and carbon atoms, to prevent such side effects. These boron-rich clusters are substituted for carbon-based benzene rings commonly found in pharmaceuticals of all types, including COX inhibitors, which give unwanted side effects.
COX activity is seen in common nonsteroidal anti-inflammatory drugs like aspirin and ibuprofen. However, prolonged use of COX inhibitors can result in a variety of negative side effects, such as possible digestive and liver problems. Some COX inhibitors have recently been pulled from the market due to an increased risk of heart complications.
The protein transythyretin acts as a shuttle to transport thyroxine, a hormone, throughout the body. As the least important of the three blood proteins that carry thyroxine, transthyretin also has a tendency to fall apart and form tough, insoluble plaques, sometimes causing injury to delicate tissues. Certain people are genetically more likely to have the proteins fall apart, increasing the risks. Investigators have found that in laboratory experiments...
Whole article: "http://www.sciencedaily.com":[ http://www.sciencedaily.com/releases/2007/04/070424180801.htm]
Related articles
Scientists Develop Artificial Blood - Scientists from the University of Sheffield are developing an artificial 'plastic blood´, which could act as a substitute for real blood in emergency situations (16.5.2007)
Alzheimer's, Parkinson's, type 2 diabetes similar at molecular level - Alzheimer's disease, Parkinson's disease, type 2 diabetes, the human version of mad cow disease, and other degenerative diseases are more closely related at the molecular level than scientists realized, a team reports this week in an advanced online publication of the journal Nature (2.5.2007)
